10-Q:季度報表
8-K:哈羅公佈2024年第一季度財務業績
SC 13D/A:超過5%持股股東披露文件(修正)-Harrow, Inc.(0.0%)
DEFA14A:其他
DEF 14A:股東委託書決議
4:持股變動聲明-股東 Opaleye Management Inc.
4:持股變動聲明-股東 Opaleye Management Inc.
4:持股變動聲明-股東 Opaleye Management Inc.
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 4:持股變動聲明-股東 Opaleye Management Inc.
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 4:持股變動聲明-高管 BAUM MARK L
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 4:持股變動聲明-股東 Opaleye Management Inc.
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 8-K:重大事件
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 8-K:重大事件
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 10-K:年度報表
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 8-K:哈羅公佈2023年第四季度和年終財務業績
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 4:持股變動聲明-高管 SAHAREK JOHN P.
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 4:持股變動聲明-高管 SAHAREK JOHN P.
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 4:持股變動聲明-高管 BOLL ANDREW R.
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 4:持股變動聲明-高管 BAUM MARK L
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 8-K:重大事件
暫無數據